Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity.

Ullmann P, Nurmik M, Schmitz M, Rodriguez F, Weiler J, Qureshi-Baig K, Felten P, Nazarov PV, Nicot N, Zuegel N, Haan S, Letellier E.

Cancer Lett. 2019 May 28;450:32-41. doi: 10.1016/j.canlet.2019.02.030. Epub 2019 Feb 18.

2.

The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.

Ullmann P, Rodriguez F, Schmitz M, Meurer SK, Qureshi-Baig K, Felten P, Ginolhac A, Antunes L, Frasquilho S, Zügel N, Weiskirchen R, Haan S, Letellier E.

Cancer Res. 2018 Jul 15;78(14):3793-3808. doi: 10.1158/0008-5472.CAN-17-3003. Epub 2018 May 10.

3.

Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence.

Letellier E, Schmitz M, Ginolhac A, Rodriguez F, Ullmann P, Qureshi-Baig K, Frasquilho S, Antunes L, Haan S.

Br J Cancer. 2017 Nov 21;117(11):1689-1701. doi: 10.1038/bjc.2017.352. Epub 2017 Oct 12.

4.

Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.

Qureshi-Baig K, Ullmann P, Haan S, Letellier E.

Mol Cancer. 2017 Feb 16;16(1):40. doi: 10.1186/s12943-017-0602-2. Review.

5.

Hypoxia-responsive miR-210 promotes self-renewal capacity of colon tumor-initiating cells by repressing ISCU and by inducing lactate production.

Ullmann P, Qureshi-Baig K, Rodriguez F, Ginolhac A, Nonnenmacher Y, Ternes D, Weiler J, Gäbler K, Bahlawane C, Hiller K, Haan S, Letellier E.

Oncotarget. 2016 Oct 4;7(40):65454-65470. doi: 10.18632/oncotarget.11772.

6.

What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue.

Qureshi-Baig K, Ullmann P, Rodriguez F, Frasquilho S, Nazarov PV, Haan S, Letellier E.

PLoS One. 2016 Jan 8;11(1):e0146052. doi: 10.1371/journal.pone.0146052. eCollection 2016. Erratum in: PLoS One. 2016;11(2):e0150179.

Supplemental Content

Loading ...
Support Center